229 related articles for article (PubMed ID: 34537845)
1. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
2. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
4. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Renaud-Picard B; Ravoninjatovo B; Abely M; Danner-Boucher I; Dubois S; Troussier F; Prevotat A; Rault G; Kessler R; Kessler L
J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
Finn E; Severn C; Pyle L; Garrish J; Vigers T; Behn CGD; Zeitler PS; Sagel SD; Nadeau KJ; Chan CL
Pediatr Pulmonol; 2023 Sep; 58(9):2495-2504. PubMed ID: 37350354
[TBL] [Abstract][Full Text] [Related]
6. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
7. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
Lek N; Acerini CL
Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
[TBL] [Abstract][Full Text] [Related]
8. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
[TBL] [Abstract][Full Text] [Related]
10. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
11. Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis.
Chan CL; Granados A; Moheet A; Singh S; Vigers T; Arbeláez AM; Yi Y; Hu S; Norris AW; Ode KL
J Clin Transl Endocrinol; 2022 Dec; 30():100311. PubMed ID: 36620757
[TBL] [Abstract][Full Text] [Related]
12. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
13. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
[TBL] [Abstract][Full Text] [Related]
14. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis.
Kirigin Biloš LS; Altabas V; Vukić Dugac A; Baretić M
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541202
[TBL] [Abstract][Full Text] [Related]
15. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
16. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Zorron M; Marson FAL; Morcillo AM; Gonçalves AC; El Beck MS; Ribeiro JD; Ribeiro AF
J Bras Pneumol; 2022; 48(2):e20210307. PubMed ID: 35475864
[TBL] [Abstract][Full Text] [Related]
17. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
18. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
19. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
20. HbA1c as a screening tool for cystic fibrosis related diabetes.
Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
